New drug combo aims to soothe Alzheimer's agitation
Symptom relief
Recruiting now
This study tests two experimental drugs, EXV-802 and EXV-801, to see if they can safely reduce agitation in people with Alzheimer's dementia. About 300 participants aged 55-90 with moderate to severe agitation will receive either the drug or a placebo twice daily for 6 weeks. The…
Phase: PHASE2, PHASE3 • Sponsor: Exciva GmbH • Aim: Symptom relief
Last updated Aug 16, 2026 00:00 UTC